The type of sciatic nerve lesions observed in patients with diabetic peripheral neuropathy was found to differ in type 1 and type 2 diabetes.
Excess weight, sleep issues more common among those with changing schedules.
Meta-analysis of two studies shows clinically significant improvement of 'minimum change in pain.'
Oral vitamin E supplementation consisting of 400 mg/day mixed tocotrienols for 1 year may not result in improved neuropathic pain symptoms in patients with diabetic peripheral neuropathy.
No benefit seen with the diet for prevention of diabetic nephropathy.
Concomitant use of these medications may result in B 12 deficiency-induced neuropathy.
A correlation was found between higher overall ambulatory volume and lower rates of appropriate diabetes monitoring.
Diabetic neuropathic pain is associated with depression, anxiety, sleep disorders, and lower quality of life in patients with type 2 diabetes.
Several nonglycemic factors may increase the risk for the development of diabetic peripheral neuropathy among people with type 1 diabetes.
Patients with osteoarthritis and diabetes experience greater knee pain and worse physical and mental status compared with patients without diabetes.